EC 1.1.1.205 (IMP dehydrogenase) inhibitor

Term ID

CHEBI:53746

Synonyms

EC 1.1.1.205 (IMP dehydrogenase) inhibitors
EC 1.1.1.205 inhibitor
EC 1.1.1.205 inhibitors
IMP dehydrogenase (EC 1.1.1.205) inhibitor
IMP dehydrogenase (EC 1.1.1.205) inhibitors
IMP dehydrogenase inhibitor
IMP dehydrogenase inhibitors
IMP oxidoreductase inhibitor
IMP oxidoreductase inhibitors
IMP:NAD(+) oxidoreductase inhibitor
IMP:NAD(+) oxidoreductase inhibitors
inosinate dehydrogenase inhibitor
inosinate dehydrogenase inhibitors
inosine 5'-monophosphate dehydrogenase inhibitors
inosine monophosphate dehydrogenase inhibitor
inosine monophosphate dehydrogenase inhibitors
inosine monophosphate oxidoreductase inhibitor
inosine monophosphate oxidoreductase inhibitors
inosinic acid dehydrogenase inhibitor
inosinic acid dehydrogenase inhibitors

(all 20)

Definition

An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of IMP dehydrogenase (EC 1.1.1.205), so blocking de novo biosynthesis of purine nucleotides.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor

EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor Show first 5 Terms
inverse has_role: curcumin mycophenolate mofetil mycophenolate sodium mycophenolic acid ribavirin 5'-monophosphate ... Show All 6 Terms

curcumin mycophenolate mofetil mycophenolate sodium mycophenolic acid ribavirin 5'-monophosphate tiazofurine Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.1.1.205 (IMP dehydrogenase) inhibitor

Phenotype where environments contain EC 1.1.1.205 (IMP dehydrogenase) inhibitor

Phenotype modified by environments containing EC 1.1.1.205 (IMP dehydrogenase) inhibitor

Human Disease Model